Disparity in circulating peripheral blood dendritic cell subsets and cytokine profile of pulmonary tuberculosis patients compared with healthy family contacts

Human Immunology

Volumn 71, Issue 7, 2010, Pages 682-691

  Gupta, Vinay ^a   Jaiswal, Anand ^b   Behera, Digamber ^b   Prasad, Hanumanthappa K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b LRS Institute of TB and Respiratory Diseases   (India)

Author keywords

IFN ; IL 12; Myeloid dendritic cells; Plasmacytoid DC; Pulmonary tuberculosis

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ACID FAST BACTERIUM; ADOLESCENT; ADULT; AGED; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FAMILY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; MYELOID DENDRITIC CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPUTUM SMEAR;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; AGED; ANTIGENS, CD; CASE-CONTROL STUDIES; CYTOKINES; DENDRITIC CELLS; FAMILY; FEMALE; HEALTH; HUMANS; IMMUNOPHENOTYPING; INTERFERON-ALPHA; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKINS; LEUKOCYTE COUNT; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; OLIGODEOXYRIBONUCLEOTIDES; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 77953916581     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.03.010     Document Type: Article

References (50)

1. Munk M.E., Emoto M. Functions of T-cell subsets and cytokines in mycobacterial infections. Eur Respir J Suppl 1995, 20:668s-675s.
2. Kadowaki N. Dendritic cells: A conductor of T cell differentiation. Allergol Int 2007, 56:193-199.
3. Robinson S.P., Patterson S., English N., Davies D., Knight S.C., Reid C.D. Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol 1999, 29:2769-2778.
4. Hart D.N. Dendritic cells: Unique leukocyte populations which control the primary immune response. Blood 1997, 90:3245-3287.
5. -ligand. J Exp Med 1997, 185:1101-1111.
6. + T cells. J Immunol 1995, 154:5071-5079.
7. Ferlazzo G., Pack M., Thomas D., Paludan C., Schmid D., Strowig T., et al. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci U S A 2004, 101:16606-16611.
8. Decalf J., Fernandes S., Longman R., Ahloulay M., Audat F., Lefrerre F., et al. Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients. J Exp Med 2007, 204:2423-2437.
9. Popov A., Driesen J., Abdullah Z., Wickenhauser C., Beyer M., Debey-Pascher S., et al. Infection of myeloid dendritic cells with Listeria monocytogenes leads to the suppression of T cell function by multiple inhibitory mechanisms. J Immunol 2008, 181:4976-4988.
10. Barchet W., Cella M., Colonna M. Plasmacytoid dendritic cells-virus experts of innate immunity. Semin Immunol 2005, 17:253-261.
11. Jego G., Palucka A.K., Blanck J.P., Chalouni C., Pascual V., Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 2003, 19:225-234.
12. Mendelson M., Hanekom W.A., Ntutela S., Vogt M., Steyn L., Maartens G., Kaplan G. Quantitative and functional differences between peripheral blood myeloid dendritic cells from patients with pleural and parenchymal lung tuberculosis. Clin Vaccine Immunol 2006, 13:1299-1306.
13. Uehira K., Amakawa R., Ito T., Tajima K., Naitoh S., Ozaki Y., et al. Dendritic cells are decreased in blood and accumulated in granuloma in tuberculosis. Clin Immunol 2002, 105:296-303.
14. Lichtner M., Rossi R., Mengoni F., Vignoli S., Colacchia B., Massetti A.P., et al. Circulating dendritic cells and interferon-alpha production in patients with tuberculosis: Correlation with clinical outcome and treatment response. Clin Exp Immunol 2006, 143:329-337.
15. Matsuda H., Suda T., Hashizume H., Yokomura K., Asada K., Suzuki K., et al. Alteration of balance between myeloid dendritic cells and plasmacytoid dendritic cells in peripheral blood of patients with asthma. Am J Respir Crit Care Med 2002, 166:1050-1054.
16. Pichyangkul S., Endy T.P., Kalayanarooj S., Nisalak A., Yongvanitchit K., Green S., et al. A blunted blood plasmacytoid dendritic cell response to an acute systemic viral infection is associated with increased disease severity. J Immunol 2003, 171:5571-5578.
17. Jangpatarapongsa K., Chootong P., Sattabongkot J., Chotivanich K., Sirichaisinthop J., Tungpradabkul S., et al. Vivax parasites alter the balance of myeloid and plasmacytoid dendritic cells and the induction of regulatory T cells. Eur J Immunol 2008, 38:2697-2705.
18. Chehimi J., Campbell D.E., Azzoni L., Bacheller D., Papasavvas E., Jerandi G., et al. Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals. J Immunol 2002, 168:4796-4801.
19. Urban B.C., Cordery D., Shafi M.J., Bull P.C., Newbold C.I., Williams T.N., Marsh K. The frequency of BDCA3-positive dendritic cells is increased in the peripheral circulation of Kenyan children with severe malaria. Infect Immun 2006, 74:6700-6706.
20. Martino A., Sacchi A., Sanarico N., Spadaro F., Ramoni C., Ciaramella A., et al. Dendritic cells derived from BCG-infected precursors induce Th2-like immune response. J Leukoc Biol 2004, 76:827-834.
21. Hashimoto K., Maeda Y., Kimura H., Suzuki K., Masuda A., Matsuoka M., Makino M. Mycobacterium leprae infection in monocyte-derived dendritic cells and its influence on antigen-presenting function. Infect Immun 2002, 70:5167-5176.
22. Henderson R.A., Watkins S.C., Flynn J.L. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J Immunol 1997, 159:635-643.
23. Anis M.M., Fulton S.A., Reba S.M., Liu Y., Harding C.V., Boom W.H. Modulation of pulmonary dendritic cell function during mycobacterial infection. Infect Immun 2008, 76:671-677.
24. Wolf A.J., Linas B., Trevejo-Nunez G.J., Kincaid E., Tamura T., Takatsu K., Ernst J.D. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J Immunol 2007, 179:2509-2519.
25. Latchumanan V.K., Singh B., Sharma P., Natarajan K. Mycobacterium tuberculosis antigens induce the differentiation of dendritic cells from bone marrow. J Immunol 2002, 169:6856-6864.
26. Kanto T., Inoue M., Miyatake H., Sato A., Sakakibara M., Yakushijin T., et al. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J Infect Dis 2004, 190:1919-1926.
27. Van Overtvelt L., Andrieu M., Verhasselt V., Connan F., Choppin J., Vercruysse V., et al. Cruzi down-regulates lipopolysaccharide-induced MHC class I on human dendritic cells and impairs antigen presentation to specific CD8(+) T lymphocytes. Int Immunol 2002, 14:1135-1144.
28. Kao J.Y., Rathinavelu S., Eaton K.A., Bai L., Zavros Y., Takami M., et al. Helicobacter pylori-secreted factors inhibit dendritic cell IL-12 secretion: A mechanism of ineffective host defense. Am J Physiol Gastrointest Liver Physiol 2006, 291:G73-G81.
29. Barcelos W., Martins-Filho O.A., Guimaraes T.M., Oliveira M.H., Spindola-de-Miranda S., Carvalho B.N., Toledo Vde P. Peripheral blood mononuclear cells immunophenotyping in pulmonary tuberculosis patients before and after treatment. Microbiol Immunol 2006, 50:597-605.
30. Verbon A., Juffermans N., Van Deventer S.J., Speelman P., Van Deutekom H., Van Der Poll T. Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin Exp Immunol 1999, 115:110-113.
31. Vankayalapati R., Wizel B., Weis S.E., Klucar P., Shams H., Samten B., Barnes P.F. Serum cytokine concentrations do not parallel Mycobacterium tuberculosis-induced cytokine production in patients with tuberculosis. Clin Infect Dis 2003, 36:24-28.
32. Bhattacharyya S., Singla R., Dey A.B., Prasad H.K. Dichotomy of cytokine profiles in patients and high-risk healthy subjects exposed to tuberculosis. Infect Immun 1999, 67:5597-5603.
33. Deveci F., Akbulut H.H., Turgut T., Muz M.H. Changes in serum cytokine levels in active tuberculosis with treatment. Mediat Inflamm 2005 2005, 5:256-262.
34. Gately M.K., Renzetti L.M., Magram J., Stern A.S., Adorini L., Gubler U., Presky D.H. The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses. Annu Rev Immunol 1998, 16:495-521.
35. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000, 13:715-725.
36. Pflanz S., Timans J.C., Cheung J., Rosales R., Kanzler H., Gilbert J., et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 2002, 16:779-790.
37. Pereira C.B., Palaci M., Leite O.H., Duarte A.J., Benard G. Monocyte cytokine secretion in patients with pulmonary tuberculosis differs from that of healthy infected subjects and correlates with clinical manifestations. Microbes Infect 2004, 6:25-33.
38. Khader S.A., Pearl J.E., Sakamoto K., Gilmartin L., Bell G.K., Jelley-Gibbs D.M., et al. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J Immunol 2005, 175:788-795.
39. Singhal A., Jaiswal A., Arora V.K., Prasad H.K. Modulation of gamma interferon receptor 1 by Mycobacterium tuberculosis: A potential immune response evasive mechanism. Infect Immun 2007, 75:2500-2510.
40. Fortune S.M., Solache A., Jaeger A., Hill P.J., Belisle J.T., Bloom B.R., et al. Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms. J Immunol 2004, 172:6272-6280.
41. Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., Bloom B.R. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993, 178:2249-2254.
42. + T cells mediate IFN-gamma-independent control of Mycobacterium tuberculosis infection both in vitro and in vivo. J Immunol 2003, 171:4689-4699.
43. Kawakami K., Kinjo Y., Uezu K., Miyagi K., Kinjo T., Yara S., et al. Interferon-gamma production and host protective response against Mycobacterium tuberculosis in mice lacking both IL-12p40 and IL-18. Microbes Infect 2004, 6:339-349.
44. Scharton-Kersten T., Caspar P., Sher A., Denkers E.Y. Toxoplasma gondii: Evidence for interleukin-12-dependent and-independent pathways of interferon-gamma production induced by an attenuated parasite strain. Exp Parasitol 1996, 84:102-114.
45. Garofalo R.P., Hintz K.H., Hill V., Ogra P.L., Welliver R.C.Sen Production of interferon gamma in respiratory syncytial virus infection of humans is not associated with interleukins 12 and 18. J Med Virol 2004, 73:289-294.
46. Subauste C.S., Wessendarp M. Human dendritic cells discriminate between viable and killed Toxoplasma gondii tachyzoites: Dendritic cell activation after infection with viable parasites results in CD28 and CD40 ligand signaling that controls IL-12-dependent and -independent T cell production of IFN-gamma. J Immunol 2000, 165:1498-1505.
47. Samten B., Thomas E.K., Gong J., Barnes P.F. Depressed CD40 ligand expression contributes to reduced gamma interferon production in human tuberculosis. Infect Immun 2000, 68:3002-3006.
48. Manca C., Tsenova L., Bergtold A., Freeman S., Tovey M., Musser J.M., et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta. Proc Natl Acad Sci U S A 2001, 98:5752-5757.
49. + T cells. J Exp Med 1993, 178:1655-1663.
50. Giosue S., Casarini M., Alemanno L., Galluccio G., Mattia P., Pedicelli G., et al. Effects of aerosolized interferon-alpha in patients with pulmonary tuberculosis. Am J Respir Crit Care Med 1998, 158:1156-1162.